BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 1998
View Archived Issues
Lilly and Dura collaborate to develop pulmonary delivery of insulin
Read More
Dura and Spiros update development of Spiros products
Read More
Aviron presents new clinical data for FluMist at ICAAC
Read More
Bayer and Novalon enter collaborative agreement to discover antiinfective drugs
Read More
NPS Pharmaceuticals initiates clinical trials for NPS-1776
Read More
Gene Activated erythropoietin enters phase III clinical trials
Read More
Guilford, RPR amend Gliadel marketing and distribution agreement
Read More
Major pediatric study supports safety and efficacy of pneumococcal vaccine
Read More
Twice-daily Viracept as safe and effective as the approved t.i.d. schedule
Read More
Novel erythromycins from HMR useful for Gram-positive and other infections
Read More
Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa
Read More
BASF patents new series with endothelin-antagonist activity
Read More
Neurogen compounds interacting with CRF1 receptors for stress-related disorders
Read More
Peptides that bind to MHC class II proteins in development at Zeneca
Read More
Selectin inhibitors described by Sanwa Kagaku for inflammatory disorders
Read More
Progesterone antagonists claimed for cancer, gynecological disorders by Meiji Seika
Read More
Agents for dementia a focus of R&D at Sanofi
Read More
ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action
Read More
Japanese investigators design novel class of NMDA receptor channel blocker
Read More
Potent, long-acting TxA2 receptor antagonist enters Pfizer development pipeline
Read More
Comparative in vitro antipneumococcal activity of CFC-222 presented at ICAAC
Read More
MEN-10700 highly active against pneumococci, gonococci and meningococci
Read More
Promising new rhinovirus 3C protease inhibitor emerges from Agouron R&D
Read More
Results from human pharmacokinetic studies support once-daily dosing for MK-991
Read More
Rhone-Poulenc Rorer's CombiPatch now available in the U.S.
Read More
Elan invests in Ligand; Ligand obtains certain rights to Morphelan
Read More
MC-02479/RWJ-54428: in vitro activity and pharmacokinetics in animals
Read More
Fujisawa withdraws NDA for vamicamide
Read More
